Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Whole Body Regeneration01:33

Whole Body Regeneration

3.6K
Regeneration is the process of restoring injured or lost tissues, organs, or body parts. While simpler organisms generally show greater ability to regenerate their whole body, few complex animals show similarly exceptional regeneration. For example, planarian flatworms have a unique regenerative potential making them a popular study organism among biologists to understand the mechanisms of whole body regeneration. Other organisms, such as hydra, also show extreme regeneration potential;...
3.6K
Compounds Essential to Human Function01:25

Compounds Essential to Human Function

7.6K
The human body is composed of cells that are fundamentally made up of several different molecules. These molecules are essential to carry out all physiological processes in the body and are broadly classified into organic and inorganic based on their chemical structures.
Inorganic Compounds Essential to Human Functioning
Inorganic compounds essential to human functioning include water, salts, acids, and bases. These compounds are inorganic, i.e., they do not have a carbon-hydrogen bond. Water...
7.6K
Buffer Systems in the Body01:19

Buffer Systems in the Body

5.5K
Chemical buffers play a critical role in the body's regulation of pH levels. These systems contain one or more compounds that stabilize pH changes by neutralizing strong acids or bases. When pH levels drop, hydrogen ions bind to a weak base; when pH levels rise, hydrogen ions are released. This dynamic process helps maintain pH within a narrow and stable range essential for normal physiological function.
A typical buffer system in bodily fluids includes a weak acid and its corresponding...
5.5K
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

78
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
78

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Unlocking New Hope: Advances in the Application of Mesenchymal Stromal Cells in Female Infertility.

Current stem cell research & therapy·2026
Same author

Geometric-Topology-Driven Membrane Design for Suppressing Polysulfide Crossover in Aqueous Redox Flow Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Electrical coupling between transplanted cardiomyocytes and host myocardium to prevent arrhythmia.

Disease models & mechanisms·2026
Same author

Lipopolysaccharide promotes rheumatoid arthritis by enhancing Wnt7b mediated macrophage-FLS communication.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

THBS1 Induces Dysfunction of Ovarian Granulosa Cells in Patients with Polycystic Ovary Syndrome by Activating the TGF-β/Smad Pathway.

Biomedicines·2026
Same author

Entropy-stabilized quinary sulfide nanozyme for complementary dual-mode detection of sulfonamide antibiotics via electrochemiluminescence and colorimetric sensing.

Biosensors & bioelectronics·2026

関連する実験動画

Updated: May 5, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.8K

TBX20は,ヒトの直接的な心臓再プログラム中に収縮性とミトコンドリア機能を改善する.

Yawen Tang1, Sajesan Aryal2,3, Xiaoxiao Geng1

  • 1Department of Biomedical Engineering (Y.T., X.G., V.G.F., J.Z., Y.Z.), Heersink School of Medicine, School of Engineering, University of Alabama at Birmingham.

Circulation
|September 14, 2022
PubMed
まとめ
この要約は機械生成です。

再プログラムカクテルに TBX20 を加えると 機能的な心筋細胞に 直接的な心臓の再プログラムが改善されます これは心臓の機能とミトコンドリアの呼吸を向上させ 心筋修復の有望な戦略を提供します

キーワード:
細胞を再プログラムするフィブロブラスト心臓筋細胞,心臓再生する転写因子

さらに関連する動画

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.3K
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K

関連する実験動画

Last Updated: May 5, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.8K
Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.3K
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K

科学分野:

  • 心血管生物学
  • 幹細胞生物学
  • 分子心臓科

背景:

  • 直接的な心臓再プログラムでは 線維細胞を心筋細胞に変換することで 心筋を再生します
  • 標準的なカクテルを用いた現在の方法では 機能的なヒト誘発心筋細胞が不足しています
  • 効率的な心臓の再プログラミングを制御する 分子メカニズムは まだ十分に理解されていません

研究 の 目的:

  • ヒトの線維細胞を機能的な心筋細胞に直接再プログラムする新たな要因を特定する.
  • 心臓細胞の運命変換と心筋細胞の成熟におけるTBX20の役割を明らかにする.

主な方法:

  • ヒト誘発心筋細胞と本来の心筋細胞のトランスクリプトミック比較
  • MGT133再プログラムカクテル (MEF2C,GATA4,TBX5,miR-133) に TBX20 を追加した.
  • トランスクリプトミクス,クロマチン占有量,表遺伝子ミクスを含む包括的な分析.

主要な成果:

  • TBX20は標準のMGT133カクテルによって活性化されない重要な遺伝子として特定されました.
  • MGT+TBX20カクテルは心臓の再プログラム効率と心臓筋細胞機能を大幅に改善しました.
  • 強化されたヒト誘発心筋細胞は,鼓動,カルシウム処理,ミトコンドリア呼吸,収縮性を改善した.

結論:

  • TBX20はMGT因子と連携して心臓増強剤を活性化し,効率的な細胞運命変換を促進します.
  • TBX20強化による再プログラムにより,収縮性およびミトコンドリア活性を含む優れた機能特性を有するヒト誘発心筋細胞が生成されます.
  • この戦略は心臓病に対する 改善された細胞ベースの治療法を開発する可能性を秘めています